期刊文献+

Transportation characteristics of nolatrexed in three tumor cell lines

Transportation characteristics of nolatrexed in three tumor cell lines
下载PDF
导出
摘要 Objective: To investigate the association of the transportation characteristics of nolatrexed in tumor cells with its drug sensitivity. Methods: The sensitivity of 3 tumor cell lines, C6, SRS82 and LoVo, to nolatrexed were determined by growth inhibition study. After exposure to 20 μmol/L nolatrexed at different time intervals ranging from 0 to 30 min, or to nolatrexed at different concentrations ranging from 0 to 40 μmol/L for 10 min, the intracellular drug concentration was measured using high-performance liquid chro-matography. Results: C6 was the most sensitive cell line among the three, with sensitivity 6. 8-fold and 13. 8-fold those of SRS-82 and LoVo cells respectively. Transportation of nolatrexed in the 3 cell lines were qualitatively similar, which rapidly achieved steady-state within 5 min, and linear relationship between the intracellular and extracellular drug concentration was observed. The intracellular steady-state level achieved in C6 was significantly higher than those in the other two cell lines, the latter having comparable levels. Conclusion: Nolatrexed enters the cell very quickly and different transport capacities are involved in the generation of varied sensitivity to nolatrexed in tumor cells. Objective:To investigate the association of the transportation characteristics of nolatrexed in tu-mor cells with its drug sensitivity. Methods: The sensitivity of 3 tumor cell lines, C6, SRS82 and LoVo, to nolatrexed were determined by growth inhibition study. After exposure to 20μmol/L nolatrexed at different time intervals ranging from 0 to 30 rain, or to nolatrexed at different concentrations ranging from 0 to 40μmol/L for 10 min, the intracellular drug concentration was measured using high-performance liquid chro-matography. Results: C6 was the most sensitive cell line among the three, with sensitivity 6.8-fold and 13.8-fold those of SRS-82 and LoVo cells respectively. Transportation of nolatrexed in the 3 cell lines were qualitatively similar, which rapidly achieved steady-state within 5 min, and linear relationship between the in-tracellular and extracellular drug concentration was observed. The intracellular steady-state level achieved in C6 was significantly higher than those in the other two cell lines, the latter having comparable levels. Con-clusion: Nolatrexed enters the cell very quickly and different transport capacities are involved in the genera-tion of varied sensitivity to nolatrexed in tumor cells.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2002年第4期304-307,共4页 中国人民解放军军医大学学报(英文版)
基金 Research Foundation of Guangdong Province (No. 99-Z-030-01)
关键词 NOLATREXED TRANSPORTATION sensitivity tumor cell high-performance liquid chromatography 肿瘤细胞 细胞转运 药物敏感性 nolatrexed 肿瘤生长
  • 相关文献

参考文献10

  • 1[1]Longo GS, Izzo J, Gorlick R et al. Characterization and drug sensitivity of four newly established colon adenocarcinoma cell lines to antifolate inhibitors of thymidylate synthase [J]. Oncol Res, 2000;12(8):309
  • 2[2]Estlin EJ, Pinkerton CR, Lewis IJ et al. A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation [J]. Br J Cancer, 2001;84(1):11
  • 3[3]Mok TS, Leung TW, Lee SD et al. A multi-centre randomized phase Ⅱstudy of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma [J]. Cancer Chemother Pharmacol, 1999;44(4):307
  • 4[4]Takemura Y, Kobayashi H, Miyachi H. Cellular and molecular mechanisms of resistance to antifolate drugs : New analogues and approaches to overcome the resistance [J]. Int J Hematol, 1997;66(4): 459
  • 5[5]Estlin EJ, Balmanno K, Calvert AH et al. The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ in human leukaemia and colorectal carcinoma cell lines [J]. Br J Cancer, 1997;76(12):1579
  • 6[6]Shaw D, Berger FG, Spencer HT. Retroviral expression of Escherichia coli thymidylate synthase cDNA confers high-level antifolate resistance to hematopoietic cells [J]. Hum Gene Ther, 2001;12(1): 51
  • 7[7]Van Triest B, Pinedo HM, Giaccone G et al. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylaste synthase inhibitors [J]. Ann Oncol, 2000;11(4):385
  • 8[8]Webber S, Bartlett CA, Boritzki TJ et al. AG337, a novel lipophilic thymidylate synthase inhibitor: In vitro and vivo preclinical studies [J]. Cancer Chemother Pharmacol, 1996; 37(6): 509
  • 9[9]Fry DW, Besserer JA. Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired transportation as a mechanism of resistance to lipophilic antifolates [J]. Cancer Res, 1988;48(24 Pt 1) : 6986
  • 10[10]Assaraf YG, Borgnia MJ. Differential reversal of lipophilic antifolate resistance in mammalian cells with modulations of the multidrug resistance phenotype [J]. Anti-cancerDrugs, 1993; 4(3): 395

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部